Maital Shemesh Rasmussen Net Worth

What's Maital Rasmussen's mailing address?

Maital's mailing address filed with the SEC is MATAM PARK, BUILDING #5, , HAIFA, L3, 3508409.

Insiders trading at Pluri Inc

Over the last 17 years, insiders at Pluri Inc have traded over $7,081,854 worth of Pluri Inc stock and bought 2,345,914 units worth $14,327,834 . The most active insiders traders include Wolf Capital Limited Part..., Zami Aberman a Israel Ben Yoram. On average, Pluri Inc executives and independent directors trade stock every 64 days with the average trade being worth of $54,123. The most recent stock trade was executed by Zami Aberman on 10 February 2022, trading 80,616 units of PSTI stock currently worth $145,109.

What does Pluri Inc do?

Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late-stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off- the-shelf, without tissue matching. Pluristem has a strong intellectual property position; a

Pluri Inc executives and stock owners

Pluri Inc executives and other stock owners filed with the SEC include:

• Yaacov Yanay,
  Pres, CEO & Director
• Zalman Aberman,
  Executive Chairman of the Board
• Yaky Yanay,
  President, Chief Executive Officer, Director
• Chen Franco-Yehuda,
  Chief Financial Officer, Treasurer, Secretary
• Dana Rubin,
  Director of Investor Relations
• Moria Kwiat,
  Independent Director
• Mark Germain,
  Independent Director
• Isaac Braun,
  Independent Director
• Doron Shorrer,
  Lead Independent Director
• Dr. Nitsan Halevy M.D.,
  Chief Medical Officer
• Efrat Livne-Hadass,
  VP of HR
• Lior Raviv,
  Chief Technology Officer
• Israel Ben Yoram,
  Director
• Nachum Rosman,
  Director
• Hava Meretzki,
  Director
• Erez Egozi,
  Chief Financial Officer
• Shai Pines,
  Director
• Boaz Gur Lavie,
  CFO
• Wolf Capital Limited Part...,
  10% owner
• Maital Shemesh Rasmussen,
  Director
• Rami Avraham Levi,
  Director
• Pinhas Doron Birger,
  Director
• Varda Shalev,
  Director
• Zami Aberman,
  Director